Keyphrases
Akt Activation
16%
AKT Pathway
16%
AKT1
16%
Antiestrogen
16%
Autocrine Growth Factors
16%
AZD5363
16%
Breast Cancer Subtypes
16%
Carcinoma Cells
16%
Cas9 Protein
16%
Cell Growth
16%
Cell Survival
16%
Clinical Intervention
16%
Conditioned Medium
16%
E-cadherin
100%
Estrogen Treatment
16%
Growth Assay
16%
Growth Factor Receptor Signaling
16%
Growth Factor Signaling
100%
Growth Factors
16%
Growth Hormone Receptor
16%
Hypersensitization
16%
Invasive Lobular Carcinoma
100%
Knock
16%
Lobular Breast Cancer
100%
MK-2206
16%
MRNA-seq
16%
Oncogenic mutations
33%
Pathway Activity
16%
Pathway mutation
16%
Pharmacological Inhibitors
16%
Phosphatidylinositol 4-phosphate 5-kinase (PIP5K)
66%
PIK3CA
16%
Production Activities
16%
Protein Array Analysis
16%
Reverse Phase Protein Array
16%
Treatment Regimen
16%
Tumor
16%
Tumor Growth
16%
Medicine and Dentistry
8 [4 (1 Aminocyclobutyl)phenyl] 9 Phenyl 1,2,4 triazolo[3,4 f][1,6]naphthyridin 3(2h) One
16%
Anaphylaxis
16%
Antiestrogen
16%
Breast Cancer
100%
Capivasertib
16%
Carcinoma Cell
16%
Cas9
16%
Cell Growth
16%
Cell Survival
16%
Clinical Intervention
16%
Clustered Regularly Interspaced Short Palindromic Repeat
16%
Estrogen Therapy
16%
Growth Factor
100%
Growth Factor Receptor
33%
Knock Out
16%
Lobular Carcinoma
100%
Messenger RNA
16%
Neoplasm
16%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
50%
Pi3K/Akt Signaling
16%
Protein Microarray
16%
Tumor Progression
16%
Uvomorulin
100%
Pharmacology, Toxicology and Pharmaceutical Science
8 [4 (1 Aminocyclobutyl)phenyl] 9 Phenyl 1,2,4 triazolo[3,4 f][1,6]naphthyridin 3(2h) One
16%
Anaphylaxis
16%
Antiestrogen
16%
Breast Cancer
100%
Capivasertib
16%
Growth Factor
100%
Growth Factor Receptor
33%
Lobular Carcinoma
100%
Messenger RNA
16%
Neoplasm
16%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
66%
Tumor Growth
16%
Uvomorulin
100%
Biochemistry, Genetics and Molecular Biology
AKT1
16%
Cadherin
100%
Cell Growth
16%
Cell Survival
16%
CRISPR/Cas9
16%
Growth Factor
100%
Growth Factor Receptor
33%
Messenger RNA
16%
Phosphatidylinositol-4,5-bisphosphate 3-Kinase
50%
Pi3K/Akt Signaling
16%
Protein Microarray
16%
Tumor Progression
16%